Zhu Linjia, Zhang Zhenfeng, Zhang Sibi, Jiang Xiuhong, Ni Yan
Department of Anesthesiology and Perioperative medicine, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Ann Palliat Med. 2021 Mar;10(3):2439-2447. doi: 10.21037/apm-20-1774. Epub 2021 Jan 11.
In balanced anesthesia, protocol during the last 30 min is very important to guarantee rapid emergence and smooth extubation. In clinical practice, sevoflurane and propofol are often used in combination to achieve a better anesthetic effect and less adverse reaction. Approximately 30 min before surgical completion, sevoflurane inhalation is often discontinued and propofol is adjusted to keep sufficient depth of anesthesia. However, propofol-based anesthesia may delay time to emergence due to its unpredictable interindividual variability. In contrast, sevoflurane can be rapidly excreted unchanged from the respiratory tract, and more importantly, with minimal variability. This study aimed to investigate the effect of a novel balanced anesthesia protocol, that is propofol-based intravenous induction, propofol-sevoflurane combined maintenance, and total sevoflurane inhalation during the last 30 min of the surgery, on the time to emergence/extubation.
In our study, a total of 100 female patients undergoing modified radical mastectomy were enrolled. All patients received propofol-based intravenous anesthesia for induction followed by propofolsevoflurane combined maintenance. Approximately 30 min before the end of surgery, sevoflurane was continually inhaled without propofol infusion in group Sev (n=50), while propofol was only infused in group Pro (n=50). The primary outcome was the time to emergence/extubation. The second outcomes included time to respiratory recovery, and duration of post-anesthesia care unit (PACU) stay. The hemodynamic parameters and incidences of postoperative adverse events such as hypoxemia, nausea, vomiting, dizziness, and emergence agitation (EA) were also assessed.
The time to emergence/extubation in group Sev was shorter than that in group Pro (12.74±4.31 vs. 17.74±4.27 min, P<0.0001). Similarly, time to respiratory recovery, and duration of PACU stay were significantly shortened in group Sev (all P<0.0001). Most of the patients in group Sev were extubated under a totally waking state of consciousness. The hemodynamic parameters and incidences of postoperative hypoxemia, nausea, vomiting, dizziness, and EA during the PACU stay were similar between the two groups.
In patients undergoing modified radical mastectomy, this novel balanced anesthesia method could shorten the time to emergence/extubation and better waking state without increasing the incidence of adverse events.
在平衡麻醉中,手术最后30分钟的麻醉方案对于确保快速苏醒和顺利拔管非常重要。在临床实践中,七氟烷和丙泊酚常联合使用以获得更好的麻醉效果和更少的不良反应。在手术结束前约30分钟,通常停止吸入七氟烷并调整丙泊酚剂量以维持足够的麻醉深度。然而,基于丙泊酚的麻醉可能因其个体间不可预测的变异性而延迟苏醒时间。相比之下,七氟烷可经呼吸道迅速原形排出,更重要的是,变异性极小。本研究旨在探讨一种新型平衡麻醉方案,即丙泊酚静脉诱导、丙泊酚-七氟烷联合维持以及手术最后30分钟全程吸入七氟烷,对苏醒/拔管时间的影响。
本研究共纳入100例行改良根治性乳房切除术的女性患者。所有患者均接受丙泊酚静脉麻醉诱导,随后丙泊酚-七氟烷联合维持麻醉。在手术结束前约30分钟,七氟烷组(n = 50)持续吸入七氟烷且不输注丙泊酚,丙泊酚组(n = 50)仅输注丙泊酚。主要结局指标为苏醒/拔管时间。次要结局指标包括呼吸恢复时间和麻醉后恢复室(PACU)停留时间。同时评估血流动力学参数以及术后低氧血症、恶心、呕吐、头晕和苏醒期躁动(EA)等不良事件的发生率。
七氟烷组的苏醒/拔管时间短于丙泊酚组(12.74±4.31 vs. 17.74±4.27分钟,P<0.0001)。同样,七氟烷组的呼吸恢复时间和PACU停留时间也显著缩短(均P<0.0001)。七氟烷组的大多数患者在完全清醒状态下拔管。两组在PACU停留期间的血流动力学参数以及术后低氧血症、恶心、呕吐、头晕和EA的发生率相似。
对于行改良根治性乳房切除术的患者,这种新型平衡麻醉方法可缩短苏醒/拔管时间并改善苏醒状态,且不增加不良事件的发生率。